Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Vitrolife

93.30 SEK

+0.81 %

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue867.0960.03,609.0842.0871.0835.0892.03,440.0
EBITDA289.0337.0962.0257.0243.0253.0196.0949.0
EBIT174.0224.0783.0151.0137.0144.0-5,267.0-4,835.0
EBIT-%20.1 %23.3 %21.7 %17.9 %15.7 %17.2 %-590.5 %-140.6 %
Profit before taxes155.0183.0674.0141.0132.0131.0-5,290.0-4,886.0
Net income116.0140.0514.0100.0100.0102.0-5,315.0-5,013.0
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.